Log In
BCIQ
Print this Print this
 

Quantose IR test

  Manage Alerts
Collapse Summary General Information
Company Metabolon Inc.
DescriptionDiagnostic to identify insulin resistance from fasting measurements of insulin, alpha-hydroxybutyrate, linoleoyl-glycerophosphocholine and oleate
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationEndocrine, Diagnostic
Indication DetailsDiagnose insulin resistance in pre-diabetic patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/29/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today